Infants and young children are typically at high risk of respiratory tract infections with viruses because of the immaturity of the respiratory tract and immune system. Clear evidence says that children are susceptible hosts to SARS-CoV-2 infection, but frequently do not have symptomatology or show mild disease. These findings raise the possibility that children could be
The nature and duration of the immunity generated by the SARA-CoV-2 infection is unknown what is a critical determinant of the future impact of the pathogen. The presence or absence of protective immunity due to infection or vaccination is still under research. There is currently no evidence that people who have recovered from the disease
Current antiviral drugs are not effective and are not recommended for COVID-19.Treatment must include supportive care to help alleviate symptoms and vital organ function in severe cases. REFERENCE Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26, 450-452. DOI:https://doi.org/10.1038/s41591-020-0820-9 Paraskevis,